Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospital, Rouen
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Men and women over 18 years of age
Histologically- or cytologically- confirmed non-small cell lung cancer diagnostic
Stage I, II or IIIA NSCLC (according to version 7 of the International Association for the Study of Lung Cancer Staging Manual in Thoracic Oncology). Staging must have included an abdominal and thoracic CTscan, a CTscan or MRI of the brain and a 18FDG PETscan
Subjects for whom a surgical resection is indicated
Signed written informed consent
You may not be if
\- previous, ongoing or planned neo-adjuvant treatment (chemotherapy, targeted therapy, immunotherapy or radiotherapy)
contraindications to general anesthesia
contraindication to the planned surgical resection
history of immunosuppressive disorder
known history of testing positive for human immunodeficiency virus
subjects with a condition requiring systemic treatment with either corticosteroids or other immunosuppressive medications within 30 days of randomization.
clinical suspicion of active infection (either acute or chronic)
severe (hemoglobin \< 8.0 g/dL) or symptomatic anemia
women of childbearing potential must have a negative urine pregnancy test
women must not be breastfeeding
prisoners or subjects who are involuntarily incarcerated
subjects under guardianship
Clareo Health | Association Between Circulating Immune Cells and the Tumor Immune Contexture in Resectable Non-small Cell Lung Cancer
